scorecardresearch
Add as a preferred source on Google
Monday, February 16, 2026
TopicPfizer

Topic: Pfizer

Can Indian courts refuse foreign judicial requests? Supreme Court to ‘settle the law’ on comity

In US case involving Pfizer, SC to clarify extent of India’s obligations to assist foreign courts under the Hague Convention, and the principle of judicial comity. 

China promotes business to foreign corporate leaders like Apple, Pfizer amid intensifying US tariffs

Trump imposed 20% tariffs on all Chinese goods in January, accusing Beijing of not doing enough to stem the flow of fentanyl into the United States, straining relations between both.

Why the Indian health minister didn’t even offer a chair to this vaccine firm executive

In ‘Braving a Viral Storm’, Aashish Chandorkar and Suraj Sudhir examine India’s vaccine journey during the Covid-19 pandemic

Moderna sues Pfizer, BioNTech for infringing its Covid vaccine patent

The company said the rival vaccine makers breached patents that covered its ‘foundational mRNA technology’.

Pfizer’s Covid vaccine safe & effective for children under 5, says US FDA

A lower rate of adverse reactions was seen in trials of the youngest kids, compared with trials of older age groups, the Food and Drug Administration (FDA) report said.

WHO adds Pfizer’s 2-drug antiviral Paxlovid to Covid recommendations for high-risk patients

WHO Guideline Development Group recommends oral drug Paxlovid for patients with non-severe Covid-19 who are at high risk of hospitalisation.

Pfizer’s combo drug Paxlovid could reduce risk of severe Covid by 89%, shows trial in US

Pfizer researchers conducted phase 2/3 clinical trial among unvaccinated Covid patients who had symptoms but weren’t in hospital, and were at high risk of disease becoming severe.

Pfizer begins making hybrid Covid vaccine that targets Omicron & original virus

Pfizer will evaluate the new formulation against an Omicron-specific shot, and determine which is best suited to move forward by March, the drug giant’s CEO Albert Bourla said.

US clears Merck’s Covid pill as it weighs how to ration Pfizer drug

Regulators are signaling they prefer Pfizer’s pill, which they’ve bought more of, but the US will have a lot more early on of Merck’s pill, which is 'better' than no treatment.

Booster dose of 6 Covid vaccines is safe, increases immunity, shows study in Lancet

The study looked at safety, immune response and side-effects of seven vaccines — Oxford-AstraZeneca, Pfizer-BioNTech, Novavax, Janssen, Moderna, Valneva and Curevac.

On Camera

The debate about spheres of influence reorders India’s position

New world reordering tests New Delhi’s strategic autonomy, balancing ties without succumbing to exclusive dominance zones.

Urban co-op banks doubled loan book in 5 yrs, but stuck at under 2% of credit market—Sahakar Trends

UCBs accounted for 1.8% of total industry credit in September 2025—down from 2.2% five yrs ago—showing that they are losing ground to faster PSU banks.

US military commander, envoy Sergio Gor visit Indian Army Western Command, Bengaluru next

At the Western Army Command, the American delegation was briefed on the capabilities of the formation, past operations and the path ahead.

The new Great Game—Trump’s playing for time, China for leverage & India for wiggle room

This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they’d seen marginal interest. The starkest example is India & Europe.